Advertisement
Advertisement

WVE

WVE logo

Wave Life Sciences Ltd. Ordinary Shares

6.10
USD
Sponsored
+0.08
+1.33%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

6.08

-0.02
-0.41%

Wave Life Sciences Ltd. Ordinary Shares Profile

About

WAVE Life Sciences Pte. Ltd. is a preclinical biopharmaceutical company. It designs, develops and commercializes nucleic acid therapeutic candidates for Huntington's disease, Duchenne muscular dystrophy and inflammatory bowel disease. Huntington's disease, the Company has programs targeting HTT SNP-1 and HTT SNP-2; DMD, targeting Exon 51 and in IBD, it is targeting SMAD7. The Company has late-stage discovery programs in epidermolysis bullosa simplex, in which it is targeting KRT14 SNP-1 and KRT14 SNP-2 and in DMD, it is focused on an additional DMD target, Activin Receptor type IIb. WAVE Life Sciences Pte. Ltd. is based in Singapore.

Info & Links

CEO

Paul B. Bolno

Headquarters

7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER
SINGAPORE, U0 018936, SINGAPORE

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.wavelifesciences.com

Auditor

KPMG LLP

Share holders

7

Employees

317

Wave Life Sciences Ltd. Ordinary Shares Statistics

Valuation Measures

Market Capitalization2

1.20B

Enterprise Value

829.06M

Enterprise Value/EBITDA(ttm)

-3.97

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

18.39

Price to Book(mrq)

2.65

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-309.73%

Profit Margin(ttm)

-1034.25%

Return on Equity(ttm)

-50.36%

Return on Invested Capital(ttm)

-73.89%

Return on Assets(ttm)

-40.06%

Income Statement

Revenue(ttm)

65.37M

Revenue Per Share(ttm)

0.33

Gross Profit(ttm)

65.37M

EBITDA(ttm)3

-208.75M

Net Income Available to Common(ttm)

-202.47M

Diluted EPS(ttm)

-1.09

Share Statistics

Beta (5Y Monthly)

-1.26

52-Week Change

-24.97%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

197.05M

Dividend Yield

0.00%

Float4

149.16M

% Held by Insiders

24.30%

% Held by Institutions

89.73%

Balance Sheet

Total Cash(mrq)

490.60M

Total Cash Per Share(mrq)

2.49

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

9.99%

Quick Ratio(mrq)

9.99%

Book Value Per Share(mrq)

2.35

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.55

Free Cash Flow(ytd)

-114.46M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement